3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Renal Cell
3
Carcinoma, Hepatocellular
3
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasms
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
AZD 6244
2
cabozantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neurofibroma, Plexiform
×
cabozantinib
×
Clear all
NCT06502171
2026-03-12
NF113
University of Alabama at Birmingham
Phase 1
Not yet recruiting
30 enrolled